DK0811008T3 - Bicycliske benzazepinderivater som vasopressinantagonister - Google Patents
Bicycliske benzazepinderivater som vasopressinantagonisterInfo
- Publication number
- DK0811008T3 DK0811008T3 DK96903711T DK96903711T DK0811008T3 DK 0811008 T3 DK0811008 T3 DK 0811008T3 DK 96903711 T DK96903711 T DK 96903711T DK 96903711 T DK96903711 T DK 96903711T DK 0811008 T3 DK0811008 T3 DK 0811008T3
- Authority
- DK
- Denmark
- Prior art keywords
- vasopressin antagonists
- benzazepine derivatives
- bicyclic
- bicyclic benzazepine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/373,839 US5696112A (en) | 1995-01-17 | 1995-01-17 | Fused heterocyclic azepines as vasopressin antagonists |
| PCT/US1996/001096 WO1996022294A1 (en) | 1995-01-17 | 1996-01-16 | Bicyclic benzazepine derivatives as vasopressin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0811008T3 true DK0811008T3 (da) | 2004-01-26 |
Family
ID=23474102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96903711T DK0811008T3 (da) | 1995-01-17 | 1996-01-16 | Bicycliske benzazepinderivater som vasopressinantagonister |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5696112A (pt) |
| EP (1) | EP0811008B1 (pt) |
| JP (1) | JPH10512572A (pt) |
| KR (1) | KR19980703098A (pt) |
| CN (1) | CN1177356A (pt) |
| AR (1) | AR010195A1 (pt) |
| AT (1) | ATE251166T1 (pt) |
| AU (1) | AU716008B2 (pt) |
| BR (1) | BR9607153A (pt) |
| CA (1) | CA2210571A1 (pt) |
| CZ (1) | CZ224697A3 (pt) |
| DE (1) | DE69630209T2 (pt) |
| DK (1) | DK0811008T3 (pt) |
| EA (1) | EA001427B1 (pt) |
| ES (1) | ES2207672T3 (pt) |
| HU (1) | HUP9800466A3 (pt) |
| IL (1) | IL116776A (pt) |
| MX (1) | MX9705312A (pt) |
| NZ (1) | NZ302119A (pt) |
| PT (1) | PT811008E (pt) |
| TW (1) | TW342385B (pt) |
| WO (1) | WO1996022294A1 (pt) |
| ZA (1) | ZA96298B (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7338796A (en) * | 1995-11-09 | 1997-05-29 | Japan Tobacco Inc. | Five-membered fused heterocyclic azepine derivatives and pharmaceutical use thereof |
| US6235900B1 (en) | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
| US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
| US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
| US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| WO2002083685A1 (en) | 2001-04-12 | 2002-10-24 | Wyeth | Cyclohexylphenyl vasopressin agonists |
| US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| JP2004530668A (ja) | 2001-04-12 | 2004-10-07 | ワイス | バソプレッシンアゴニストとしてのｎ−ビフェニルカルボニル−およびｎ−フェニルピリジルカルボニル置換二および三環アゼピンおよびジアゼピン |
| US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
| US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| EP1632494A1 (en) * | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
| CA2636826C (en) * | 2006-01-18 | 2011-11-29 | F.Hoffmann-La Roche Ag | Thiazoles as 11 beta-hsd1 inhibitors |
| EP2403860B1 (en) * | 2009-03-04 | 2015-11-04 | IDENIX Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole as hcv polymerase inhibitors |
| WO2010116176A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity |
| WO2017175000A1 (en) | 2016-04-08 | 2017-10-12 | Pulmocide Limited | Compounds |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA821020B (en) * | 1981-02-18 | 1983-10-26 | Thomae Gmbh Dr K | Azepine derivatives, process for their preparation and pharmaceutical compositions thereof |
| US4766108A (en) * | 1986-12-04 | 1988-08-23 | Smith Kline Beckman Corporation | Tyr-Arg-vasopressin antagonists |
| US5055448A (en) * | 1987-06-25 | 1991-10-08 | Medical College Of Ohio | Linear derivatives of arginine vasopressin antagonists |
| DK0382185T3 (da) * | 1989-02-10 | 1994-07-04 | Otsuka Pharma Co Ltd | Carbostyrilderivater |
| DE122009000062I2 (de) * | 1989-10-20 | 2011-01-13 | Otsuka Pharma Co Ltd | Benzoheterozyklische verbindungen |
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| US5070187A (en) * | 1989-11-03 | 1991-12-03 | Trustees Of Boston University | Pharmacologically effective antagonists of arginine-vasopressin |
| TW199153B (pt) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk | |
| CA2066104C (en) * | 1991-04-19 | 2003-05-27 | Hidenori Ogawa | Benzazepine derivatives as vasopressin antagonists |
| EP0533243B1 (en) * | 1991-09-16 | 1997-12-17 | Merck & Co. Inc. | Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives |
| EP0533240A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| EP0533242A3 (en) * | 1991-09-16 | 1993-09-15 | Merck & Co. Inc. | Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| US5204349A (en) * | 1991-09-16 | 1993-04-20 | Merck & Co., Inc. | Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
| US5498609A (en) * | 1992-08-20 | 1996-03-12 | Otsuka Pharmaceutical Company, Limited | Benzoazepinyl compounds as oxytocin and vasopressin antagonists |
| TW270927B (pt) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd | |
| WO1994012476A1 (en) * | 1992-11-25 | 1994-06-09 | Yamanouchi Pharmaceutical Co., Ltd. | Benzanilide derivative |
| WO1994014796A1 (en) * | 1992-12-21 | 1994-07-07 | Yamanouchi Pharmaceutical Co., Ltd. | Novel n-(pyridylcarbonyl)benzazepine derivative and intermediate therefor |
| AU6219994A (en) * | 1993-03-11 | 1994-09-26 | Yamanouchi Pharmaceutical Co., Ltd. | Compound with vasopressin antagonism |
| GB9307527D0 (en) * | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
-
1995
- 1995-01-17 US US08/373,839 patent/US5696112A/en not_active Expired - Lifetime
- 1995-06-02 US US08/460,418 patent/US5654297A/en not_active Expired - Lifetime
-
1996
- 1996-01-15 ZA ZA96298A patent/ZA96298B/xx unknown
- 1996-01-15 AR ARP960101028A patent/AR010195A1/es not_active Application Discontinuation
- 1996-01-16 AT AT96903711T patent/ATE251166T1/de not_active IP Right Cessation
- 1996-01-16 EA EA199700115A patent/EA001427B1/ru not_active IP Right Cessation
- 1996-01-16 PT PT96903711T patent/PT811008E/pt unknown
- 1996-01-16 WO PCT/US1996/001096 patent/WO1996022294A1/en active IP Right Grant
- 1996-01-16 TW TW085100460A patent/TW342385B/zh active
- 1996-01-16 MX MX9705312A patent/MX9705312A/es not_active IP Right Cessation
- 1996-01-16 BR BR9607153A patent/BR9607153A/pt unknown
- 1996-01-16 KR KR1019970704946A patent/KR19980703098A/ko not_active Application Discontinuation
- 1996-01-16 HU HU9800466A patent/HUP9800466A3/hu unknown
- 1996-01-16 ES ES96903711T patent/ES2207672T3/es not_active Expired - Lifetime
- 1996-01-16 DK DK96903711T patent/DK0811008T3/da active
- 1996-01-16 JP JP8522453A patent/JPH10512572A/ja not_active Ceased
- 1996-01-16 CN CN96192356A patent/CN1177356A/zh active Pending
- 1996-01-16 CA CA002210571A patent/CA2210571A1/en not_active Abandoned
- 1996-01-16 DE DE69630209T patent/DE69630209T2/de not_active Expired - Fee Related
- 1996-01-16 EP EP96903711A patent/EP0811008B1/en not_active Expired - Lifetime
- 1996-01-16 CZ CZ972246A patent/CZ224697A3/cs unknown
- 1996-01-16 IL IL11677696A patent/IL116776A/xx not_active IP Right Cessation
- 1996-01-16 NZ NZ302119A patent/NZ302119A/en unknown
- 1996-01-16 AU AU47706/96A patent/AU716008B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EA001427B1 (ru) | 2001-02-26 |
| HUP9800466A2 (hu) | 1998-07-28 |
| AU716008B2 (en) | 2000-02-17 |
| BR9607153A (pt) | 1997-11-11 |
| ATE251166T1 (de) | 2003-10-15 |
| EP0811008A1 (en) | 1997-12-10 |
| DE69630209T2 (de) | 2004-08-19 |
| WO1996022294A1 (en) | 1996-07-25 |
| EP0811008B1 (en) | 2003-10-01 |
| TW342385B (en) | 1998-10-11 |
| NZ302119A (en) | 2000-02-28 |
| CZ224697A3 (cs) | 1998-01-14 |
| PT811008E (pt) | 2004-02-27 |
| EA199700115A1 (ru) | 1997-12-30 |
| JPH10512572A (ja) | 1998-12-02 |
| AU4770696A (en) | 1996-08-07 |
| AR010195A1 (es) | 2000-06-07 |
| MX9705312A (es) | 1997-10-31 |
| IL116776A0 (en) | 1996-05-14 |
| US5696112A (en) | 1997-12-09 |
| KR19980703098A (ko) | 1998-10-15 |
| IL116776A (en) | 2000-10-31 |
| HUP9800466A3 (en) | 1998-12-28 |
| CN1177356A (zh) | 1998-03-25 |
| DE69630209D1 (de) | 2003-11-06 |
| ZA96298B (en) | 1997-07-15 |
| US5654297A (en) | 1997-08-05 |
| ES2207672T3 (es) | 2004-06-01 |
| CA2210571A1 (en) | 1996-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0514667T3 (da) | Benzazepinderivater som vasopressinantagonister | |
| DK0804438T3 (da) | Tricycliske benzazepin-vasopressinantagonister | |
| DK0805813T3 (da) | Tricyclic vasopressin antagonists | |
| DK0811008T3 (da) | Bicycliske benzazepinderivater som vasopressinantagonister | |
| BR9606977A (pt) | Antagonistas de vasopressina de benzazepina triciclica | |
| DK0738150T3 (da) | Bicykliske fibrinogene antagonister | |
| ATE381570T1 (de) | Trizyclische benzazepin-vasopressin-antagoniste | |
| BR9710087A (pt) | Antagonistas de vasopressina de benzazepina tricíclicos | |
| BR9612126A (pt) | Derivados de benzazepina | |
| DK1147115T5 (da) | Tricycliske benzodiazepiner som vasopressinreceptorantagonister | |
| DE69826487D1 (de) | Trizyclische vasopressin agoniste | |
| NO974043D0 (no) | Indolderivater som EAA-antagonister | |
| FI951798A0 (fi) | Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina | |
| PT964867E (pt) | Antagonistas da taquicinima | |
| FI943359A0 (fi) | Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina | |
| BR1100543A (pt) | antagonistas bicìclicos de fibrinogênio | |
| FI941117A0 (fi) | Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina | |
| SI0804438T1 (sl) | Triciklicni benzazepinski antagonisti vazopresina |